| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Revenue | $1.54B | +20.4% |
| Cost of Revenue | $1.01B | +18.9% |
| Gross Profit | $530.5M | +23.2% |
| R&D Expense | $65.3M | +10.0% |
| SG&A Expense | $269.7M | +18.1% |
| Operating Income | $189.1M | +39.8% |
| Pre-tax Income | $161.2M | +39.9% |
| Income Tax | $33.1M | +40.9% |
| Net Income | $128.2M |
| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $95.4M | +24.2% |
| Accounts Receivable | $648.2M | +70.2% |
| Inventory | $397.9M | +17.7% |
| Current Assets | $1.22B | +44.7% |
| Total Assets | $1.94B | +24.4% |
| Current Liabilities | $814.6M | +42.5% |
| Long-term Debt | $137.6M | -4.9% |
| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$87.5M | -192.3% |
| Capital Expenditures | $22.1M | +39.8% |
| Investing Cash Flow | -$37.6M | +7.0% |
| Financing Cash Flow | $144.3M | +488.0% |
| Free Cash Flow | -$109.6M | -238.7% |
| +39.6% |
| EPS (Basic) | $7.55 | +38.5% |
| EPS (Diluted) | $7.38 | +38.2% |
| Total Liabilities |
| $1.07B |
| +29.3% |
| Stockholders' Equity | $863.5M | +18.9% |